These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2990769)

  • 1. Plasma Na+-K+ ATPase inhibitory activity in normal and hypertensive subjects: relationship to intracellular electrolytes and blood pressure.
    Boschi S; Borghi C; Costa FV; Ambrosioni E
    Clin Exp Hypertens A; 1985; 7(5-6):735-53. PubMed ID: 2990769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+, K(+)-ATPase inhibition and intracellular electrolyte content in essential and secondary hypertension.
    Spieker C; Zidek W; Rahn KH
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):309-14. PubMed ID: 1647795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral factors in borderline hypertension.
    Ambrosioni E; Costa FV; Borghi C; Boschi S; Mussi A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 5():S15-22. PubMed ID: 2427878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Na+ + K+) ATPase inhibitors and intracellular electrolytes in essential hypertension.
    Iwaoka T; Nugent CA; Umeda T; Sato T
    Jpn Heart J; 1987 Sep; 28(5):695-705. PubMed ID: 2828706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralymphocytic sodium concentration: a sensitive index to identify young subjects at risk of hypertension.
    Ambrosioni E; Costa FV; Montebugnoli L; Borghi C; Vasconi L; Tartagni F; Magnani B
    Clin Exp Hypertens (1978); 1981; 3(4):675-91. PubMed ID: 7297320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term plasma renin activity suppression by saline and release of a plasma endogenous Na/K ATPase inhibitor in essential hypertension.
    Borghi C; Boschi S; Munarini A; Mussi A; Costa FV; Ambrosioni E
    Am J Hypertens; 1990 Feb; 3(2):98-104. PubMed ID: 2155004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary free cortisol is not a biochemical marker of hypertension.
    Krall P; Carvajal C; Ortiz E; Muñoz C; Garrido JL; Mosso L; Fardella C
    Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary magnesium supplementation on diurnal variations of blood pressure and plasma Na+, K(+)-ATPase activity in essential hypertension.
    Haga H
    Jpn Heart J; 1992 Nov; 33(6):785-800. PubMed ID: 1338597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na-K-adenosine triphosphatase and cation content in the erythrocyte in essential hypertension.
    Rahman M; Koh H; Primera MI; Del Greco F; Quintanilla AP
    J Lab Clin Med; 1986 Apr; 107(4):337-41. PubMed ID: 3007645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma sodium-potassium ATPase inhibition activity in low- and normal-renin hypertension.
    Keane P; Burgess E; Watanabe M; Wong T
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):9-13. PubMed ID: 1848765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte Na+,K(+)-ATPase properties and adenylate energy charge in normotensives and in essential hypertensives.
    Canestrari F; Galli F; Boschi S; Albertini MC; Gheller G; De Crescentini S; Bossú M
    Clin Chim Acta; 1994 Jan; 224(2):167-79. PubMed ID: 8004787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure in essential hypertension correlates with the concentration of a circulating inhibitor of the sodium pump.
    Moreth K; Kuske R; Renner D; Schoner W
    Klin Wochenschr; 1986 Mar; 64(5):239-44. PubMed ID: 3009961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-erythrocyte sodium and (Na+,K+-activated)-ATPase concentration and urinary aldosterone excretion in spontaneously hypertensive rats.
    Berglund G; Sigström L; Lundin S; Karlberg BE; Herlitz H
    Clin Sci (Lond); 1981 Feb; 60(2):229-32. PubMed ID: 6263538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cation imbalance in erythrocytes, serum and 24-hour urine from patients with essential hypertension and adolescents with high blood pressure.
    Tochikubo O; Sasaki O; Umemura S; Goto E; Fujishima S; Kaneko Y
    Jpn Circ J; 1982 May; 46(5):512-22. PubMed ID: 7077814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic factor modulates the plasma levels of a Na+/K+ATPase inhibitor in volume expanded borderline hypertensives.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):618-22. PubMed ID: 1651740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant difference in the effect of acute saline loading on plasma Na-K ATPase inhibitor and blood pressure between children and adults with essential hypertension.
    Uchiyama M; Sakai K
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):91-7. PubMed ID: 1317474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.